Anti-Lipid Drugs

An attack of acute pancreatitis is likely to be the first presenting symptom of this lipoprotein disorder:
1. familial combined hyperlipoproteinemia
2. familial ligand-defective ApoB
3. familial lipoprotein lipase or cofactor deficiency
4. familial dysbetalipoproteinemia
Secondary cause of hypercholesterolemia:
1. diabetes mellitus
2. alcohol ingestion
3. cholestasis
4. lipodystrophy
5. the estrogens
Clinical symptoms associated with primary chylomicronemia:
1. eruptive xanthomas
2. hepatosplenomegaly
3. hypersplenism
4. lipid-laden foam cells in bone marrow
5. all of the above
Despite strict dietary control, this condition can induce a marked increase in triglyceride serum concentration in a patient with primary chylomicronemia:
1. chronic obstructive pulmonary disease
2. pregnancy
3. both
4. neither
Principal lipoprotein manifestation of heterozygous familial hypercholesterolemia
1. increased chylomicrons
2. increased LDL
Niacin could be used to treat which one(s) of the following lipoprotein disorders?
1. moderate familial hypertriglyceridemia
2. Lp(a) hyperlipoproteinemia
3. familial dysbetalipoproteinemia
4. severe familial hypertriglyceridemia
5. all of the above
Treatment of choice for hyperlipidemia associated with chronic nephrotic syndrome:
1. diet
2. gemfibrozil (Lopid)
3. bile acid-binding presence with niacin
Anti-lipid drug that usually causes cutaneous vasodilation after each dose when the drug is started
1. gemfibrozil (Lopid)
2. niacin (vitamin B3)
3. cholestyramine (Questran, Questran Light)
4. clofibrate (Abitrate, Atromid-S)
5. lovastatin (Mevacor)